COMMUNIQUÉS West-GlobeNewswire
-
Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
25/08/2026 -
Immatics Announces $150 Million Underwritten Offering
25/08/2026 -
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
25/08/2026 -
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
25/08/2026 -
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
25/08/2026 -
Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders
25/08/2026 -
Trading in GN Store Nord shares by board members, executives and associated persons
25/08/2026 -
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
25/08/2026 -
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
25/08/2026 -
4DMT to Participate in Upcoming Investor Conferences
25/08/2026 -
Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
25/08/2026 -
Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease
25/08/2026 -
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
25/08/2026 -
Transactions in connection with share buy-back program
25/08/2026 -
Trading by management and close relations of management
25/08/2026 -
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage
25/08/2026 -
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
25/08/2026 -
Barinthus Bio Provides Update on Proposed Combination with Clywedog Therapeutics
25/08/2026 -
TerrAscend Announces Results of Special Meeting of Shareholders
25/08/2026
Pages